Risk for incident arterial or venous vascular events varies over the course of systemic lupus erythematosus

Journal of Rheumatology

Volumn 33, Issue 9, 2006, Pages 1780-1784

  Chang, Erika R ^a   Pineau, Christian A ^b   Bernatsky, Sasha ^c   Neville, Carolyn ^c   Clarke, Ann E ^d   Fortin, Paul R ^e,f  

^a RHODE ISLAND HOSPITAL   (United States)

^b RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c MONTREAL GENERAL HOSPITAL   (Canada)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Disease duration; Systemic lupus erythematosus; Thrombovascular events

Indexed keywords

ADULT; ARTERY THROMBOSIS; ARTICLE; CONFIDENCE INTERVAL; DATA ANALYSIS; DESCRIPTIVE RESEARCH; DISEASE COURSE; FEMALE; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; VEIN THROMBOSIS;

ADULT; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; QUEBEC; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; THROMBOSIS;

EID: 33748548074     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 1976;60:221-5.
2. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine Baltimore 2003;82:299-308.
3. Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997;145:408-15.
4. Ward MM. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 1999;42:338-46.
5. Somers E, Magder LS, Petri M. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. J Rheumatol 2002;29:2531-6.
6. White RH. The epidemiology of venous thromboembolism. Circulation 2003;107 Suppl 1:I4-I8.
7. Petri M. Cardiovascular lupus. In: Lahita RG, editor. Systemic lupus erythematosus. Amsterdam: Elsevier; 2004:913-42.
8. Brouwer JL, Bijl M, Veeger NJ, Kluin-Nelemans HC, van der Meer J. The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus. Blood 2004;104:143-8.
9. Shariati Sarabi Z, Chang E, Bobba R, et al. The incidence rates of arterial and venous thrombosis after diagnosis of systemic lupus erythematosus. Arthritis Rheum 2005;53:609-12.